MedPath

Study of Osteogenesis Imperfecta Tendon

Recruiting
Conditions
Osteogenesis Imperfecta
Registration Number
NCT06065111
Lead Sponsor
Université Catholique de Louvain
Brief Summary

Osteogenesis imperfecta (OI) is a rare genetic disease due to a mutation in one of the genes encoding either type I collagen or a protein involved in its synthesis. This leads to bone fragility with fractures and deformities. However, other tissues rich in type I collagen can also be affected, such as teeth or vessel walls.

In the literature, several case reports describe tendon ruptures in OI patients, but no original study has really addressed this issue, which is likely to impact the quality of life through a reduction in mobility and pain.

Recent work carried out by the investigators shows an alteration of the osteotendinous unit in the osteogenesis imperfecta mouse (oim), a validated model of the most severe form of OI. Consequently, the project aims to study the damage of tendon and ligament in patients suffering from osteogenesis imperfecta.

Detailed Description

This project aims to study the damage of tendon and ligament in a cohort of patients suffering from osteogenesis imperfecta. The data collected will be put into perspective with those of our first experimental work on mice. They will also make it possible to complete the specific care of these patients. Indeed, during the anamnesis, particular attention will be paid to the description of tendon-ligament pain in order to propose the most effective treatment for this kind of disorder, mainly in physiotherapy. Prevention work will surely be necessary with patients and caregivers.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria
  • to have an osteogenesis imperfecta
Exclusion Criteria
  • none, since we want to study different types of osteogenesis imperfecta and consider the effect of age.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tendon stiffnessThroughout the entire study, approximately during 22 months

Triceps suralis tendon, from zero to infinity, expressed in Newton/mm², a high value indicates a high stiffness

Secondary Outcome Measures
NameTimeMethod
Mobility : walking testThroughout the entire study, approximately during 22 months

Timed-up and go (if walking is possible for the patient)

Pain localization and intensity for childrenThroughout the entire study, approximately during 22 months

face scale

KinesiophobiaThroughout the entire study, approximately during 22 months

Tampa questionnaire

Quality of life for adultsThroughout the entire study, approximately during 22 months

Medical Outcomes Study 36-item Short-Form Health Survey

Quality of life for childrenThroughout the entire study, approximately during 22 months

Pediatric Quality of Life Inventory

Grip strength testThroughout the entire study, approximately during 22 months

Dynamometer

Pain localization and intensity for adultsThroughout the entire study, approximately during 22 months

visual analogue scale

Trial Locations

Locations (1)

Pole de Morphologie

🇧🇪

Woluwe-Saint-Lambert, Brussels, Belgium

Pole de Morphologie
🇧🇪Woluwe-Saint-Lambert, Brussels, Belgium
Antoine Chretien, PT
Contact
+32 2 764 52 27
antoine.chretien@uclouvain.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.